Peter DeMuth - 30 Sep 2024 Form 4 Insider Report for Elicio Therapeutics, Inc. (ELTX)

Role
Chief Scientific Officer
Signature
/s/ Peter DeMuth
Issuer symbol
ELTX
Transactions as of
30 Sep 2024
Net transactions value
$0
Form type
4
Filing time
02 Oct 2024, 16:13:23 UTC
Previous filing
05 Feb 2024
Next filing
18 Dec 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELTX Stock Option (Right to Buy) Award $0 +29,800 $0.000000 29,800 30 Sep 2024 Common Stock 29,800 $5.03 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fifty percent (50%) of the stock options vest on September 30, 2025, the one-year anniversary of the grant date, with the remaining fifty percent (50%) of the stock options to vest on September 30, 2026, the two-year anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.